On the stock market since 2021, it operates in the world of real estate. Now — the numbers.
The company is still in the product-building phase: its spending runs above its sales. That only changes once the product starts selling at scale.
That much dependence is a risk in itself: if this one line weakens, the whole company feels it directly.
An average decline of 7% a year over the last 4 years — the most striking risk in this picture. Red columns mark years that ended in a loss.
Before the clock runs out, either sales must climb sharply or new money must come in. For now, time is on the company’s side.
angles, checked one by one.
The 3 that stand out are on screen; the rest came back neutral.
The council scores out of 10; report-card grades are out of 100.
Revenue Growth: Sales are growing slowly.
An investor who bought at the very peak is down 87% today. The business is the same; what changed most is the price — and the expectations — the market pins on it.
Sales run at $121.8M a year. A small number, but proof the product has real buyers.
Over the last 12 months, company executives reported 6 buys and 4 sells. Management buying with its own money is usually read as a good sign.
A loss of $3.4M against $121.8M in annual sales. And on top of that, sales fell from the year before.
Since the drop from its peak, buyer appetite hasn’t come back. Council score: 0/10.
The sales tempo runs behind the sector. Council score: 2/10.
On our five-subject report card, PCOK sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”
The takeaway: PCOK is a high-risk stock — not yet profitable, and its future rides on its product catching on.